Department of Nephrology, Juntendo University Nerima Hospital, Tokyo 177-8521, Japan.
Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
Nutrients. 2022 Oct 13;14(20):4269. doi: 10.3390/nu14204269.
Background: Arterial calcification is an important factor in determining the prognosis of patients with chronic kidney disease (CKD). Few studies on aortic calcification have involved radial artery calcification (RAC). This study aimed to analyze risk factors for RAC in patients with end-stage kidney disease (ESKD) and investigate the relationship between subsequent cardiovascular events (CVE) and vascular access trouble (VAT). Methods: This cohort study included 64 consecutive patients with ESKD who initiated hemodialysis and underwent a procedure for the creation of a primary radiocephalic arteriovenous fistula (RCAVF). Small arterial specimens were obtained from patients during RCAVF surgery. Tissue samples were stained with von Kossa, and arterial microcalcification was evaluated. We analyzed the association between preexisting arterial microcalcifications, clinical characteristics, CVE, and VAT. Results: In the univariate analysis, RAC patients demonstrated high systolic blood pressure (sBP), low hemoglobin (Hb), and low transferrin saturation (TSAT) (<0.05, <0.05, and <0.05, respectively). In the multivariate analysis, Hb (HR−0.516 (0.278−0.959), p < 0.05), TSAT (HR−0.0012 (0.00000248−0.597), p < 0.05), and sBP (HR−1.037 (1.001−1.073), p < 0.05) were independent risk factors for RAC. The cumulative incidence rate of CVE/VAT was not associated with RAC for one year. Conclusion: RAC was associated with sBP, TSAT, and anemia; however, no association with CVE/VAT was observed.
动脉钙化是决定慢性肾脏病(CKD)患者预后的重要因素。很少有研究涉及桡动脉钙化(RAC)的主动脉钙化。本研究旨在分析终末期肾病(ESKD)患者 RAC 的危险因素,并探讨其与随后发生心血管事件(CVE)和血管通路问题(VAT)的关系。
本队列研究纳入了 64 例开始血液透析并进行头静脉桡动脉内瘘(RCAVF)手术的连续 ESKD 患者。在 RCAVF 手术中,从患者身上获取小动脉标本。对组织样本进行 von Kossa 染色,评估动脉微钙化。我们分析了动脉微钙化、临床特征、CVE 和 VAT 之间的关联。
在单因素分析中,RAC 患者的收缩压(sBP)较高、血红蛋白(Hb)较低、转铁蛋白饱和度(TSAT)较低(分别为<0.05、<0.05 和<0.05)。在多因素分析中,Hb(HR-0.516(0.278-0.959),p<0.05)、TSAT(HR-0.0012(0.00000248-0.597),p<0.05)和 sBP(HR-1.037(1.001-1.073),p<0.05)是 RAC 的独立危险因素。CVE/VAT 的累积发生率与 RAC 在一年内无关联。
RAC 与 sBP、TSAT 和贫血有关,但与 CVE/VAT 无关。